(Q34993059)

English

HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

author name string

Jana Kostolanská

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Vladimír Jakus

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

L'ubomír Barák

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

1 May 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Journal of Pediatric Endocrinology and Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

433-442

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Oxidative stress in the pathogenesis of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Impact of metabolic control and serum lipids on the concentration of advanced glycation end products in the serum of children and adolescents with type 1 diabetes, as determined by fluorescence spectroscopy and nepsilon-(carboxymethyl)lysine ELISA.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Sorbitol dehydrogenase overexpression potentiates glucose toxicity to cultured retinal pericytes

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Novel therapeutics for diabetic micro- and macrovascular complications.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Longitudinal analysis of low-molecular weight fluorophores in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Advanced glycation end products in children with chronic renal failure and type 1 diabetes

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Evaluation of some biochemical changes in diabetic patients

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

The meaning of serum levels of advanced glycosylation end products in diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Glycemic control in adolescents with type 1 diabetes mellitus improves lipid serum levels and oxidative stress.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Increased serum levels of advanced glycation end products (AGEs) in children and adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Improvement in quality of diabetes control and concentrations of AGE-products in patients with type 1 and insulin-treated type 2 diabetes mellitus studied over a period of 10 years (JEVIN).

1 reference

https://api.crossref.org/works/10.1515%2FJPEM.2009.22.5.433

21 January 2018

Identifiers

10.1515/JPEM.2009.22.5.433

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34993059&oldid=1565639155"